M.J.B. Aarts - Essers

Recent publications

Leek, L. V. M., Notohardjo, J. C. L., de Joode, K., Velker, E. L., Haanen, J. B. A. G., Suijkerbuijk, K. P. M., Aarts, M. J. B., de Groot, J. W. B., Kapiteijn, E., van den Berkmortel, F. W. P. J., Westgeest, H. M., de Gruijl, T. D., Retel, V. P., Cuppen, E., van der Veldt, A. A. M., Labots, M., Voest, E. E., van de Haar, J., & van den Eertwegh, A. J. M. (2024). Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma. Scientific Reports, 14(1), Article 11244. https://doi.org/10.1038/s41598-024-61150-y
More information about this publication
Figaroa, O., Zondervan, P., Kessels, R., Berkhof, J., Aarts, M., Hamberg, P., Los, M., Piersma, D., Rikhof, B., Suelmann, B., Tascilar, M., van der Veldt, A., Verhagen, P., Westgeest, H., Yildirim, H., Bex, A., & Bins, A. (2024). PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor–based First-line Therapy in Metastatic Renal Cell Carcinoma Patients. European Urology Open Science, 70, 28-35. https://doi.org/10.1016/j.euros.2024.09.002
More information about this publication
Janssen, J. C., van Dijk, B., de Joode, K., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Jalving, M., de Jonge, M. J. A., Joosse, A., Kapiteijn, E., Kamphuis-Huismans, A. M., Naipal, K. A. T., Piersma, D., Rikhof, B., Westgeest, H. M., Vreugdenhil, G., ... van der Veldt, A. A. M. (2024). Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol. BMC Cancer, 24(1), Article 632. https://doi.org/10.1186/s12885-024-12336-0
More information about this publication
Blank, C. U., Lucas, M. W., Scolyer, R. A., van de Wiel, B. A., Menzies, A. M., Lopez-Yurda, M., Hoeijmakers, L. L., Saw, R. P. M., Lijnsvelt, J. M., Maher, N. G., Pulleman, S. M., Gonzalez, M., Torres Acosta, A., van Houdt, W. J., Lo, S. N., Kuijpers, A. M. J., Spillane, A., Klop, W. M. C., Pennington, T. E., ... Et al. (2024). Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. New England Journal of Medicine, 391(18), 1696-1708. https://doi.org/10.1056/NEJMoa2402604
More information about this publication
Özkan, A., Kapiteijn, E., van den Bos, F., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Bloem, M., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, J. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Haanen, J. B., Holtslag, C. E., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Stevense-den Boer, A. M., Suijkerbuijk, K. P. M., ... de Glas, N. A. (2024). Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry. European Journal of Cancer, 212, Article 115056. https://doi.org/10.1016/j.ejca.2024.115056
More information about this publication
Bloem, M., van Not, O. J., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, J. J., de Groot, J. W. B., Haanen, J. B., Hospers, G. A. P., Kapiteijn, E. W., de Meza, M. M., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A. M., van der Veldt, A. A. M., Vreugdenhil, G., van den Eertwegh, A. J. M., ... Wouters, M. W. J. M. (2024). Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study. International Journal of Cancer, 155(8), 1455-1465. https://doi.org/10.1002/ijc.35060
More information about this publication
van Not, O. J., van den Eertwegh, A. J. M., Jalving, H., Bloem, M., Haanen, J. B., van Rijn, R. S., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., Jan Willem de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Leeneman, B., Piersma, D., Stevense-Den Boer, M., van der Veldt, A. A. M., Gerard Vreugdenhil, G., Wouters, M. W. J. M., ... Suijkerbuijk, K. P. M. (2024). Long-Term Survival in Patients With Advanced Melanoma. Jama network open, 7(8), e2426641. Article 2426641. https://doi.org/10.1001/jamanetworkopen.2024.26641
More information about this publication
Verheijden, R. J., Burgers, F. H., Janssen, J. C., Putker, A. E., Veenstra, S. P. G. R., Hospers, G. A. P., Aarts, M. J. B., Hehenkamp, K. W., Doornebosch, V. L. E., Verhaert, M., van den Berkmortel, F. W. P. J., Chatzidionysiou, K., Llobell, A., Barros, M., Maria, A. T. J., Takeji, A., García Morillo, J. S., Lidar, M., van Eijs, M. J. M., ... Suijkerbuijk, K. P. M. (2024). Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma. European Journal of Cancer, 207, Article 114172. https://doi.org/10.1016/j.ejca.2024.114172
More information about this publication
Rauwerdink, D. J. W., Not, O. V., de Meza, M., Doorn, R. V., Hage, J. V. D., Eertwegh, A. J. M. V. D., Haanen, J. B., Aarts, M. J. B., Berkmortel, F. W. P. J. V. D., Blank, C. U., Boers-Sonderen, M. J., Groot, J. W. B. D., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Stevense-den Boer, A. M., Veldt, A. A. M. V. D., Vreugdenhil, G., Wouters, M. W. J. M., ... Kapiteijn, E. (2024). Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients. Cancers, 16(15), Article 2656. https://doi.org/10.3390/cancers16152656
More information about this publication
Meuleman, A. T., Volders, E. L. D., Lubberts, S., Kerst, J. M., Wymenga, A. N. M., Aarts, M. J. B., Goncalves, M. B., Lefrandt, J. D., Steursma, G., Meijer, J., Nuver, J., & Gietema, J. A. (2024). Vascular fi ngerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. ESMO Open, 9(7), Article 103631. https://doi.org/10.1016/j.esmoop.2024.103631
More information about this publication

Go to all publications